The company's AI engine, THEIA, specializes in using different imaging modalities for diagnostics, prognostics, or health assessment purposes, and can screen, diagnose, and prognose various diseases, including those related to cardiovascular and ocular health. With THEIA, every consultation could become a specialist consultation, regardless of where and with whom the patient consults. The diagnostic report is provided in just 10 seconds, and THEIA can determine HbA1c levels and cardiovascular risk factors via the eye, with associated prognostic capability. The company is preparing regulatory approval submissions for major agencies and welcomes enquiries from potential clinical, commercial, and research partners.